---
title: "United Imaging Healthcare (688271): Won the procurement project of Wuhan Integrated Traditional Chinese and Western Medicine Hospital, with a bid amount of 5.34 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287726627.md"
description: "United Imaging Healthcare (688271) won the procurement project of Wuhan Integrated Traditional Chinese and Western Medicine Hospital, with an amount of 5.34 million yuan. In 2025, the company's operating revenue is 13.8 billion yuan, with a growth rate of 33.98%, and a net profit of 1.869 billion yuan, with a growth rate of 48.14%. In the first quarter of 2026, the operating revenue is 2.908 billion yuan, with a growth rate of 17.34%, and a net profit of 399 million yuan, with a growth rate of 7.78%"
datetime: "2026-05-27T06:34:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287726627.md)
  - [en](https://longbridge.com/en/news/287726627.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287726627.md)
generator: "portal-rs"
---

# United Imaging Healthcare (688271): Won the procurement project of Wuhan Integrated Traditional Chinese and Western Medicine Hospital, with a bid amount of 5.34 million yuan

According to Tongbi Finance, data from Qichacha shows that, based on the "Announcement of the Bidding (Transaction) Results for the Maintenance and Repair Services of the United Imaging X-ray Computed Tomography Equipment for Wuhan Traditional Chinese and Western Medicine Hospital," Shanghai United Imaging Healthcare Technology Co., Ltd. announced on May 27, 2026, that it won the bid for the procurement project of Wuhan Traditional Chinese and Western Medicine Hospital, with a bid amount of 5.34 million yuan.

Related listed company: United Imaging Healthcare (688271.SH)

*Tongbi Finance Tip:*

*United Imaging Healthcare (688271.SH) reported an operating income of 13.8 billion yuan in 2025, with a growth rate of 33.98%. The net profit attributable to the parent company was 1.869 billion yuan, with a growth rate of 48.14%, and the return on equity was 9.00%.*

*In the first quarter of 2026, the company's operating income was 2.908 billion yuan, with a growth rate of 17.34%. The net profit attributable to the parent company was 399 million yuan, with a growth rate of 7.78%.*

*Currently, the company belongs to the healthcare industry, with the main product type being diagnostic and therapeutic equipment. The 2025 report shows the main composition of revenue as follows: sales of medical imaging diagnostic equipment and radiation therapy equipment: 82.53%; maintenance revenue: 12.38%; other businesses: 4.69%; software revenue: 0.39%.*

### Related Stocks

- [688271.CN](https://longbridge.com/en/quote/688271.CN.md)

## Related News & Research

- [Pixel 11 gets in on the digicam trend](https://longbridge.com/en/news/296639212.md)
- [14:06 ETStarlight Children's Foundation Announces 2026 Starlight Awards Honorees](https://longbridge.com/en/news/296524956.md)
- [12:35 ETCornerstone Research Announces New Senior Vice President Promotions](https://longbridge.com/en/news/296253857.md)
- [04:00 ETGlasswall launches Genesis to expand Zero Trust file protection beyond everyday files](https://longbridge.com/en/news/296193696.md)
- [11:06 ETEndurance Named to Inc. 5000 for 11th Time, Continuing National Growth](https://longbridge.com/en/news/296124358.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**